Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
18.6M
-
Number of holders
-
9
-
Total 13F shares, excl. options
-
1.07M
-
Shares change
-
+1.07M
-
Total reported value, excl. options
-
$3.02M
-
Value change
-
+$3.01M
-
Number of buys
-
9
-
Price
-
$2.83
Significant Holders of UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) as of Q3 2021
9 filings reported holding UNCY - UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share as of Q3 2021.
UNICYCIVE THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (UNCY) has 9 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.07M shares
of 18.6M outstanding shares and own 5.74% of the company stock.
Largest 9 shareholders include Nantahala Capital Management, LLC (700K shares), Board of Trustees of The Leland Stanford Junior University (248K shares), GEODE CAPITAL MANAGEMENT, LLC (26.1K shares), TWO SIGMA INVESTMENTS, LP (25.6K shares), SANDERS MORRIS HARRIS LLC (20K shares), Frontier Wealth Management LLC (18.8K shares), TANDEM CAPITAL MANAGEMENT CORP /ADV (15.5K shares), BlackRock Inc. (11.4K shares), and UBS Group AG (621 shares).
This table shows the top 9 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.